Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injury

2016 ◽  
Vol 34 (3) ◽  
pp. 433-441 ◽  
Author(s):  
Ali Darkazalli ◽  
Abdol Aziz Ould Ismail ◽  
Nastaren Abad ◽  
Samuel C. Grant ◽  
Cathy W. Levenson
2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Yun-Xing Fu ◽  
Jing Ji ◽  
Fang Shan ◽  
Jialing Li ◽  
Rong Hu

AbstractPremature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility. Clinical features of POF are hypoestrogenism or estrogen deficiency, increased gonadotropin level, and, most importantly, amenorrhea. With the development of regenerative medicine, human mesenchymal stem cell (hMSC) therapy brings new prospects for POF. This study aimed to describe the types of MSCs currently available for POF therapy, their biological characteristics, and their mechanism of action. It reviewed the latest findings on POF to provide the theoretical basis for further investigation and clinical therapy.


2015 ◽  
Vol 78 (5) ◽  
pp. 520-526 ◽  
Author(s):  
Vanessa Donega ◽  
Cora H. Nijboer ◽  
Cindy T. J. van Velthoven ◽  
Sameh A. Youssef ◽  
Alain de Bruin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document